Inactivation of West Nile virus and malaria using photosensitizers
View Patent ↗Methods and apparatuses are provided for inactivation of microorganisms in fluids or on surfaces. Preferably the fluids contain blood or blood products and comprise biologically active proteins. Preferred methods include the steps of adding an effective, non-toxic amount of a photosensitizer to a fluid and exposing the fluid to photoradiation sufficient to activate the photosensitizer whereby microorganisms are inactivated.
1. A method for treating a fluid to inactivate at least one type of parasite or virus that may be present therein, said fluid containing one or more components selected from the group consisting of: biologically active protein, blood, and blood constituents, without destroying the biological activity of such component, comprising:
(a) adding an inactivation effective, substantially non-toxic amount of an endogenous photosensitizer or endogenously-based derivative photosensitizer other than a porphyrin to the fluid; and
(b) exposing the fluid of step (a) to photoradiation sufficient to activate the photosensitizer, whereby at least one parasite or virus in the fluid is inactivated.
2. The method of claim 1 , wherein the parasite comprises P. falciparum.
3. The method of claim 1 , wherein the fluid comprises red blood cells and the photoradiation has a wavelength of about 447 nm.
4. The method of claim 1 , further comprising adding air to the fluid and photosensitizer before exposing the fluid to photoradiation.
5. The method of claim 1 , wherein the photosensitizer is a nucleic-acid-targeted non-toxic, photoactivatable compound which does not produce toxic photolytic breakdown products.
6. The method of claim 1 , wherein the photosensitizer is endogenous.
7. The method of claim 6 , wherein the photosensitizer is 7,8-dimethyl-10-ribityl isoalloxazine.
8. The method of claim 1 , wherein the virus comprises West Nile virus.
9. The method of claim 1 , wherein the photoradiation comprises one or more wavelengths in the visible spectrum.
10. The method of claim 1 , wherein the photoradiation comprises one or more wavelengths in the ultraviolet spectrum.
11. The method of claim 1 , wherein said fluid of step (a) is exposed to a source of photoradiation at a depth selected to ensure penetration of the photoradiation through the fluid and inactivation of the parasite or virus.
12. The method of claim 1 , wherein the fluid comprises blood constituents.
13. The method of claim 1 , wherein the fluid is whole blood.
14. The method of claim 1 , wherein the fluid is a separated blood product.
15. The method of claim 1 , wherein an endogenous photosensitizer is added to anticoagulant and said anticoagulant is added to the fluid.
16. The method of claim 1 , wherein the photosensitizer is capable of inactivating viruses or parasites at a pH of about 7.4.
17. The method of claim 1 , wherein the photosensitizer is capable of inactivating viruses or parasites in the presence of plasma, cells or blood components.
18. The method of claim 1 , wherein the photosensitizer inactivates at least one type of parasite or virus present in human blood.